Natco Pharma Q1 Results

  • BSE: 524816
  • NSE: NATCOPHARM
  • ISIN: INE987B01026
  • Sector: Biotechnology & Drugs
BSE
1,369.213.20 (0.97%)
Volume17.41 K
Updated: Mon 25 Nov, 2024 | 15:29:00
NSE
1,364.957.35 (0.54%)
Volume5.72 L
Updated: Mon 25 Nov, 2024 | 15:43:45
Today: 1,355.45
1,383.50
52-Wk: 752.55
1,638.35

Q1 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Natco Pharma Q1 Results

    *All figures in crores except per share values
    Fiscal PeriodJun 24Mar 23QoQ CompJun 23YoY Comp
    Total Revenue 1,362.60897.90-%1,140.50-%
    Selling/ General/ Admin Expenses Total 142.00118.90-%138.20-%
    Depreciation/ Amortization 44.1041.00-%43.50-%
    Other Operating Expenses Total 235.60181.50-%278.30-%
    Total Operating Expense 601.90599.80-%656.00-%
    Operating Income 760.70298.10-%484.50-%
    Net Income Before Taxes 803.60324.40-%500.00-%
    Net Income 668.50275.80-%420.30-%
    Diluted Normalized EPS 37.3215.10-%23.26-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts